PROGRESSIVE PULMONARY FIBROSIS
Clinical trials for PROGRESSIVE PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New inhaled therapy aims to slow lung scarring in progressive fibrosis
Disease control OngoingThis study tests an inhaled form of pirfenidone (AP01) in 375 adults with progressive pulmonary fibrosis (PPF), a condition where lung scarring worsens over time. Participants receive either a high dose, low dose, or placebo twice daily for 52 weeks, alongside their usual care. T…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Avalyn Pharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New hope for lung fibrosis patients: inhaled drug tested for long-term safety
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of an inhaled medication called treprostinil for people with fibrotic lung diseases like idiopathic pulmonary fibrosis. About 1,850 adults who completed a prior related study will take the drug and be monitored for side effects. The goal i…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for lung scarring: phase 3 trial underway
Disease control OngoingThis study tests an experimental drug, BMS-986278, in about 1057 adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. Participants receive either the drug or a placebo to see if it can slow lung function decline and is safe. The trial is …
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Breathing in xenon: a new MRI scan to see lung damage?
Knowledge-focused OngoingThis study at Duke University tests whether a special MRI scan using inhaled xenon gas can detect changes in lung function over time in people with progressive pulmonary fibrosis. Sixty adults with various types of lung scarring will have MRI scans before starting anti-fibrotic m…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:08 UTC
-
Lung disease study probes hidden environmental triggers
Knowledge-focused OngoingThis study looks at how things in the environment and at work might affect people with interstitial lung diseases (a group of lung conditions). Researchers will ask 1,000 adults with a new diagnosis about their exposures to things like pollution, chemicals, and dust. The goal is …
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
Gene study aims to unlock secrets of progressive lung disease
Knowledge-focused OngoingThis study follows 250 Italian adults with genetic forms of pulmonary fibrosis to see how their lung function changes over time. Researchers will track breathing tests and compare patients who receive immune-modulating drugs with those who do not. The goal is to understand how in…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC